Xilis Xilis is a biotechnology company that specializes in the development of precision medicine and drug discovery technologies. | ![]() Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ![]() Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. | ||
Founding Date | Founding Date 2019 | Founding Date 2001 | Founding Date 1890 | Founding Date 2010 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Durham, US HQ | Locations Kunming, CN HQ | Locations ID HQ | Locations Heze, CN HQ |
Employees | Employees 6511% decrease | Employees 2,388 | Employees 1,233 | Employees 95920% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) 708.6 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥961.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods N/A | Cost of goods ¥864.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit N/A | Gross profit ¥140.3m (FY, 2025) |
Net income | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income N/A | Net income (¥84.7m) (FY, 2025) |

Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View company